---
search:
  boost: .9
---

# Blood Formation, Coagulation, and Thrombosis Agents: Hematopoietic Agents

[Criteria Document](https://mygainwell-my.sharepoint.com/:w:/g/personal/kaelyn_dobbins_gainwelltechnologies_com/EZRvZm2uSsdHq1H_OgWBXJIB-UDk8WJTt3QyVZ1RVqOpoQ?e=y8NvVV){:target="_blank" rel="noopener}

## Criteria { data-search-exclude }

|||
| ---------- | ---------------------------------------------------------- |
| Criteria 1 | Preferred Agents- Epogen (PA), Mircera (PA), Retacrit (PA) |
| Criteria 2 | Non-Preferred Agents- Procrit                              |
| Criteria 3 | Non-Preferred Agents- Aranesp                              |

   

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong></th>
<th>Blood Formation, Coagulation, and Thrombosis Agents: Hematopoietic Agents</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong></td>
<td>Preferred Products - Epogen (PA), Mircera (PA), Retacrit (PA)</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong></td>
<td>NDC-9</td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products</strong></p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th>X</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td></td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name</td>
<td>Corresponding Code (s)</td>
<td>Type of Code (GCNSeqNo, HICL, NDC)</td>
</tr>
<tr class="even">
<td></td>
<td>EPOGEN</td>
<td>011740</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>EPOGEN</td>
<td>011741</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>EPOGEN</td>
<td>011742</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>EPOGEN</td>
<td>015164</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>EPOGEN</td>
<td>025708</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>EPOGEN</td>
<td>058592</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MIRCERA</td>
<td>063115</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MIRCERA</td>
<td>063131</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MIRCERA</td>
<td>063132</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MIRCERA</td>
<td>063133</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>MIRCERA</td>
<td>063134</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>MIRCERA</td>
<td>064736</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>RETACRIT</td>
<td>078432</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>RETACRIT</td>
<td>078433</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>RETACRIT</td>
<td>078434</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>RETACRIT</td>
<td>078435</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>RETACRIT</td>
<td>078436</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>RETACRIT</td>
<td>081692</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>RETACRIT</td>
<td>081714</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number</strong>  </th>
<th><strong>Question ID</strong>  </th>
<th><strong>Default Next Question ID</strong>  </th>
<th><strong>Question Type</strong>  </th>
<th><strong>Question Text</strong>  </th>
<th><strong>Choice Text</strong>  </th>
<th><strong>Next Question ID</strong>  </th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1 </td>
<td>1000</td>
<td> </td>
<td>Select  </td>
<td><p>What is the patient’s diagnosis? </p>
<p> </p></td>
<td>Anemia due to chronic renal failure, patient on dialysis </td>
<td>1001</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Anemia due to chronic renal failure, patient not on dialysis </td>
<td>1001</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Chemotherapy-induced anemia </td>
<td>1001</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Anemia in myelodysplastic syndrome </td>
<td>1001</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Autologous blood donation, patient will require blood transfusions</td>
<td>1001</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Anemia of prematurity, age less than or equal to 6 months </td>
<td>1001</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Anemia associated with chronic inflammatory disorders (e.g., rheumatoid arthritis) </td>
<td>1001</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Anemia associated with ribavirin combination therapy in hepatitis C-infected patient </td>
<td>1001</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Anemia in zidovudine-treated HIV-infected patients </td>
<td>1001</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Other </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>2 </td>
<td>1001</td>
<td></td>
<td>Select  </td>
<td>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?    </td>
<td>New Start (initial authorization request   </td>
<td>1002</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)</td>
<td>1233    </td>
</tr>
<tr class="odd">
<td>3 </td>
<td>1002</td>
<td></td>
<td>Select</td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?   </td>
<td>Y  </td>
<td>1234</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>4</td>
<td>1233</td>
<td></td>
<td>Select and Free Text  </td>
<td>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring? </td>
<td>Y  </td>
<td>1234 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>5</td>
<td>1234</td>
<td> </td>
<td>Select and Free Text </td>
<td><p>Has the provider submitted documentation of the patient’s hemoglobin level?</p>
<p> </p>
<p>Please note: hemoglobin is not required to be submitted for a diagnosis of anemia of prematurity, age less than or equal to 6 months.</p></td>
<td>Y </td>
<td>END (Pending Manual Review) </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>6</td>
<td>1235 </td>
<td> </td>
<td>Free Text </td>
<td>Please provide the rationale for the medication being requested.  </td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS:

  ![](docs/images/BloodBlood%20Products%20Hematopoietic%20Agents/media/image1.png)

| **Last Approved ** | 5/17/2023 |
| ------------------ | --------- |
| **Other**          |           |

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong></th>
<th>Blood Formation, Coagulation, and Thrombosis Agents: Hematopoietic Agents</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong></td>
<td>Non-Preferred Agent-Procrit</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong></td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products</strong></p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name</td>
<td>Corresponding Code (s)</td>
<td>Type of Code (GCNSeqNo, HICL, NDC)</td>
</tr>
<tr class="even">
<td></td>
<td>PROCRIT</td>
<td>011740</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>PROCRIT</td>
<td>011741</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>PROCRIT</td>
<td>011742</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>PROCRIT</td>
<td>015164</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>PROCRIT</td>
<td>025708</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>PROCRIT</td>
<td>041394</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>PROCRIT</td>
<td>058592</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number</strong>  </th>
<th><strong>Question ID</strong>  </th>
<th><strong>Default Next Question ID</strong>  </th>
<th><strong>Question Type</strong>  </th>
<th><strong>Question Text</strong>  </th>
<th><strong>Choice Text</strong>  </th>
<th><strong>Next Question ID</strong>  </th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1 </td>
<td>0998</td>
<td> </td>
<td>Select  </td>
<td><p>What is the patient’s diagnosis? </p>
<p> </p></td>
<td>Anemia due to chronic renal failure, patient on dialysis </td>
<td>0999 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Anemia due to chronic renal failure, patient not on dialysis </td>
<td>0999 </td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Chemotherapy-induced anemia </td>
<td>0999 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Anemia in myelodysplastic syndrome </td>
<td>0999 </td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Autologous blood donation, patient will require blood transfusion</td>
<td>0999 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Anemia of prematurity, age less than or equal to 6 months </td>
<td>0999</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Anemia associated with chronic inflammatory disorders (e.g., rheumatoid arthritis) </td>
<td>0999 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Anemia associated with ribavirin combination therapy in hepatitis C-infected patient </td>
<td>0999 </td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Anemia in zidovudine-treated HIV-infected patients </td>
<td>0999 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Other</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>2</td>
<td>0999 </td>
<td> </td>
<td>Select  </td>
<td>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?    </td>
<td>New Start (initial authorization request   </td>
<td>1000</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request)</td>
<td>1233</td>
</tr>
<tr class="odd">
<td>3</td>
<td>1000 </td>
<td>  </td>
<td>Select</td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?   </td>
<td>Y  </td>
<td>1001 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>4</td>
<td>1001</td>
<td> </td>
<td>Select and Free Text </td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">14 days</span> with at least <span class="underline">one</span> preferred drug? </p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y</td>
<td>1003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1002</td>
</tr>
<tr class="odd">
<td>5</td>
<td>1002</td>
<td></td>
<td>Select and Free Text </td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?  </p>
<p> </p>
<p>If yes, please submit the medication name and reason for inability to use.   </p></td>
<td>Y</td>
<td>1003</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1236</td>
</tr>
<tr class="odd">
<td>6</td>
<td>1003</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred extended release formulation</p>
<p>3) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>1004</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1234</td>
</tr>
<tr class="odd">
<td>7</td>
<td>1004</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation, inadequate clinical response with a product’s immediate release formulation, or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>1234</td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="odd">
<td>8</td>
<td>1233</td>
<td></td>
<td>Select and Free Text  </td>
<td>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring? </td>
<td>Y  </td>
<td>1234 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>9</td>
<td>1234 </td>
<td></td>
<td>Select and Free Text </td>
<td><p>Has the provider submitted documentation of the patient’s hemoglobin level?</p>
<p> </p>
<p>Please note: hemoglobin is not required to be submitted for a diagnosis of anemia of prematurity, age less than or equal to 6 months.</p></td>
<td>Y </td>
<td>END (Pending Manual Review) </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235 </td>
</tr>
<tr class="odd">
<td>10</td>
<td>1235 </td>
<td> </td>
<td>Free Text </td>
<td>Please provide the rationale for the medication being requested.  </td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
<tr class="even">
<td>11</td>
<td>1236</td>
<td></td>
<td>Free Text </td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.  </td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS:  

 ![](docs/images/BloodBlood%20Products%20Hematopoietic%20Agents/media/image1.png) 

| **Last Approved ** | 5/17/2023 |
| ------------------ | --------- |
| **Other**          |           |

<table>
<thead>
<tr class="header">
<th><strong>Criteria Title</strong></th>
<th>Blood Formation, Coagulation, and Thrombosis Agents: Hematopoietic Agents</th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Criteria Subtitle</strong></td>
<td>Non-preferred Agent- Aranesp</td>
<td></td>
<td></td>
</tr>
<tr class="even">
<td><strong>Approval Level</strong></td>
<td>GCNSeqNo</td>
<td></td>
<td></td>
</tr>
<tr class="odd">
<td><p><strong>Products</strong></p>
<table>
<thead>
<tr class="header">
<th>Preferred</th>
<th></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Non-Preferred</td>
<td>X</td>
</tr>
<tr class="even">
<td>Brand</td>
<td></td>
</tr>
<tr class="odd">
<td>Generic</td>
<td></td>
</tr>
<tr class="even">
<td>Other</td>
<td></td>
</tr>
</tbody>
</table></td>
<td>Drug Name</td>
<td>Corresponding Code (s)</td>
<td>Type of Code (GCNSeqNo, HICL, NDC)</td>
</tr>
<tr class="even">
<td></td>
<td>ARANESP</td>
<td>048583</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ARANESP</td>
<td>048584</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ARANESP</td>
<td>048585</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ARANESP</td>
<td>048586</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ARANESP</td>
<td>048587</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ARANESP</td>
<td>048908</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ARANESP</td>
<td>048911</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ARANESP</td>
<td>048913</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ARANESP</td>
<td>048914</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ARANESP</td>
<td>049630</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ARANESP</td>
<td>061006</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ARANESP</td>
<td>061269</td>
<td>GCNSeqNo</td>
</tr>
<tr class="even">
<td></td>
<td>ARANESP</td>
<td>061270</td>
<td>GCNSeqNo</td>
</tr>
<tr class="odd">
<td></td>
<td>ARANESP</td>
<td>061271</td>
<td>GCNSeqNo</td>
</tr>
</tbody>
</table>

<table>
<thead>
<tr class="header">
<th><strong>Sequence Number</strong>  </th>
<th><strong>Question ID</strong>  </th>
<th><strong>Default Next Question ID</strong>  </th>
<th><strong>Question Type</strong>  </th>
<th><strong>Question Text</strong>  </th>
<th><strong>Choice Text</strong>  </th>
<th><strong>Next Question ID</strong>  </th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>1 </td>
<td>0998</td>
<td> </td>
<td>Select  </td>
<td><p>What is the patient’s diagnosis? </p>
<p> </p></td>
<td>Anemia due to chronic renal failure, patient on dialysis </td>
<td>0999 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Anemia due to chronic renal failure, patient not on dialysis </td>
<td>0999 </td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Chemotherapy-induced anemia </td>
<td>0999 </td>
</tr>
<tr class="even">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Anemia in myelodysplastic syndrome </td>
<td>0999 </td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Other</td>
<td>1235</td>
</tr>
<tr class="even">
<td>2</td>
<td>0999 </td>
<td> </td>
<td>Select  </td>
<td>Is the patient new to therapy (initial authorization request) or continuing therapy (re-authorization request)?    </td>
<td>New Start (initial authorization request   </td>
<td>1000</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Continuation (re-authorization request) </td>
<td>1233</td>
</tr>
<tr class="even">
<td>3</td>
<td>1000 </td>
<td>  </td>
<td>Select and Free Text </td>
<td>Is this request being prescribed in accordance with Food and Drug Administration (FDA) approved labeling?   </td>
<td>Y  </td>
<td>1001 </td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235 </td>
</tr>
<tr class="even">
<td>4</td>
<td>1001</td>
<td> </td>
<td>Select and Free Text </td>
<td><p>Has the patient had an inadequate clinical response of at least <span class="underline">14 days</span> with at least <span class="underline">one</span> preferred drug? </p>
<p>If yes, please submit the medication trials and dates.</p></td>
<td>Y</td>
<td>1003</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1002</td>
</tr>
<tr class="even">
<td>5</td>
<td>1002</td>
<td></td>
<td>Select and Free Text </td>
<td><p>Has the provider submitted documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances)?  </p>
<p> </p>
<p>If yes, please submit the medication name and reason for inability to use.   </p></td>
<td>Y</td>
<td>1003</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1236</td>
</tr>
<tr class="even">
<td>6</td>
<td>1003</td>
<td></td>
<td>Select</td>
<td><p>Is the request for any of the following:</p>
<p>1) a nonsolid oral dosage formulation</p>
<p>2) a non-preferred extended release formulation</p>
<p>3) a non-preferred brand name that has a preferred generic product</p></td>
<td>Y</td>
<td>1004</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1234</td>
</tr>
<tr class="even">
<td>7</td>
<td>1004</td>
<td></td>
<td>Select and Free Text</td>
<td>Has the provider submitted documentation of medical necessity for the requested product (i.e. medical reasons for why the patient cannot be changed to a solid oral dosage formulation, inadequate clinical response with a product’s immediate release formulation, or inadequate clinical response or allergy of two or more generic labelers)?</td>
<td>Y</td>
<td>1234</td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N</td>
<td>1235</td>
</tr>
<tr class="even">
<td>8</td>
<td>1233</td>
<td></td>
<td>Select and Free Text  </td>
<td>Has the provider submitted documentation of the patient’s clinical response to treatment and ongoing safety monitoring? </td>
<td>Y  </td>
<td>1234 </td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N  </td>
<td>1235 </td>
</tr>
<tr class="even">
<td>9</td>
<td>1234 </td>
<td></td>
<td>Select and Free Text </td>
<td><p>Has the provider submitted documentation of the patient’s hemoglobin level?</p>
<p> </p></td>
<td>Y </td>
<td>END (Pending Manual Review) </td>
</tr>
<tr class="odd">
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>N </td>
<td>1235 </td>
</tr>
<tr class="even">
<td>10</td>
<td>1235 </td>
<td> </td>
<td>Free Text </td>
<td>Please provide the rationale for the medication being requested.  </td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
<tr class="odd">
<td>11</td>
<td>1236</td>
<td></td>
<td>Free Text </td>
<td>Please explain the reason(s) why the patient is unable to use medications not requiring prior approval.  </td>
<td>END (Pending Manual Review) </td>
<td></td>
</tr>
</tbody>
</table>

LENGTH OF AUTHORIZATIONS: 

![](docs/images/BloodBlood%20Products%20Hematopoietic%20Agents/media/image2.png) 

| **Last Approved ** | 5/17/2023 |
| ------------------ | --------- |
| **Other**          |           |
